NIH-funded research R15 grant

Understanding how eCigarette exposure affects inflammation in the lungs

Official title: Dissecting inflammatory outcomes following eCigarette exposure

Funded at Brigham Young University · NIH-11041654 · Data updated 2026-11-12

This study is looking at how vaping affects lung health, especially in teenagers, by exploring how certain harmful substances in e-cigarettes cause inflammation, and it hopes to find ways to reduce these negative effects.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionBrigham Young University
NIH-funded
Lab location1 site (Provo, United States)
Project startJuly 15, 2020
Project endDecember 31, 2027
Funding year2025
Award (this year)$428,639
NIH project number2R15HL152257-02
Project IDNIH-11041654 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adolescents and young adults who use eCigarettes and may be experiencing respiratory issues.

Less likely to help

Patients who do not use eCigarettes or have no history of lung-related health issues may not benefit from this research.

What this research studies

This research investigates the molecular pathways involved in inflammatory responses caused by electronic cigarette (eCig) exposure, particularly focusing on the role of the RAGE receptor. The study aims to understand how eCig aerosols, which contain harmful substances, impact lung health, especially in adolescents who are increasingly using these products. By using animal models, the research will explore the effects of eCig exposure on inflammation and potential treatments that could mitigate these harmful effects. The findings could lead to better understanding and management of lung diseases associated with vaping.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for lung inflammation caused by eCigarette use.

How similar studies have gone: While there has been some research on tobacco smoke exposure, this study is pioneering in its specific focus on eCigarette exposure and the RAGE signaling pathway.

Where this research is happening

  • Brigham Young University
    Provo, United States
    Active

Researchers

  • Principal investigator: Reynolds, Paul R — Brigham Young University
  • Study coordinator: Reynolds, Paul R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.